Starpharma Holdings Statistics
Total Valuation
Starpharma Holdings has a market cap or net worth of 26.05 million. The enterprise value is 13.69 million.
| Market Cap | 26.05M |
| Enterprise Value | 13.69M |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 377.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.51 |
| EV / Sales | 2.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.90 |
Financial Position
The company has a current ratio of 4.94, with a Debt / Equity ratio of 0.13.
| Current Ratio | 4.94 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.50 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.95% and return on invested capital (ROIC) is -13.66%.
| Return on Equity (ROE) | -25.95% |
| Return on Assets (ROA) | -11.48% |
| Return on Capital (ROIC) | -13.66% |
| Revenue Per Employee | 162,730 |
| Profits Per Employee | -136,192 |
| Employee Count | 40 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 4.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.78% in the last 52 weeks. The beta is 0.77, so Starpharma Holdings's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -34.78% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 34.90 |
| Average Volume (20 Days) | 20,131 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Starpharma Holdings had revenue of 6.51 million and -5.45 million in losses. Loss per share was -0.01.
| Revenue | 6.51M |
| Gross Profit | -619,829 |
| Operating Income | -5.45M |
| Pretax Income | -5.45M |
| Net Income | -5.45M |
| EBITDA | -5.24M |
| EBIT | -5.45M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 15.59 million in cash and 2.35 million in debt, giving a net cash position of 13.23 million.
| Cash & Cash Equivalents | 15.59M |
| Total Debt | 2.35M |
| Net Cash | 13.23M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.76M |
| Book Value Per Share | 0.05 |
| Working Capital | 17.52M |
Cash Flow
In the last 12 months, operating cash flow was -4.66 million and capital expenditures -59,381, giving a free cash flow of -4.71 million.
| Operating Cash Flow | -4.66M |
| Capital Expenditures | -59,381 |
| Free Cash Flow | -4.71M |
| FCF Per Share | n/a |
Margins
Gross margin is -9.52%, with operating and profit margins of -83.69% and -83.69%.
| Gross Margin | -9.52% |
| Operating Margin | -83.69% |
| Pretax Margin | -83.69% |
| Profit Margin | -83.69% |
| EBITDA Margin | -80.45% |
| EBIT Margin | -83.69% |
| FCF Margin | n/a |
Dividends & Yields
Starpharma Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.59% |
| Shareholder Yield | -0.59% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Starpharma Holdings has an Altman Z-Score of -4.48. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.48 |
| Piotroski F-Score | n/a |